Dechra Veterinary Products has launched Floxabactin (enrofloxacin), a new antibiotic product to treat urinary tract infections in dogs and upper respiratory tract infections in cats.

Floxabactin is indicated for use in dogs with lower UTIs including those associated with prostatitis, upper urinary tract infections caused by Escherichia coli or Proteus mirabilis in dogs, and superficial and deep pyoderma. For cats, the 15 mg dose can be used with upper respiratory tract infections.

Floxabactin is presented in blister packs: 15mg for cats and dogs, plus 50mg and 150mg for dogs.

Dechra Brand Manager Carol Morgan said: “Floxabactin has been developed with the responsible administration of antibiotics in mind. We would always promote only using antimicrobials when an infection has been documented and based on the results of culture and sensitivity testing, and or cytology testing, if applicable.

"Other treatment options should also be considered before the systemic use of antibiotics such as topical treatment for superficial  pyoderma."

For more information, visit: https://www.dechra.co.uk/new-from-dechra 

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.